SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5wh6'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GSE_A_EAAA224_1 (GLUTATHIONE TRANSFERASE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 12	ARG A 129 LEU A 191 LEU A 260 VAL A 264 ALA A 198	None	1.04A	1gseA-5wh6A: undetectable	1gseA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UHO_A_VDNA1000_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	6 / 10	TYR A 159 HIS A 160 PHE A 340 GLN A 369 GLY A 371 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 (-4.5A) AKJ A 601 (-3.0A) None AKJ A 601 (-4.1A)	0.33A	1uhoA-5wh6A: 36.6	1uhoA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 12	HIS A 200 MET A 273 THR A 333 GLN A 369 PHE A 372	ZN A 602 (-3.3A) AKJ A 601 ( 3.9A) AKJ A 601 (-4.1A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	1.49A	1xlxA-5wh6A: 52.2	1xlxA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	12 / 12	TYR A 159 HIS A 160 HIS A 204 MET A 273 LEU A 319 ASN A 321 THR A 333 ILE A 336 MET A 337 SER A 368 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None None AKJ A 601 ( 3.9A) AKJ A 601 ( 4.6A) AKJ A 601 (-4.3A) AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) AKJ A 601 (-2.5A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.43A	1xlxA-5wh6A: 52.2	1xlxA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 12	HIS A 200 MET A 273 THR A 333 GLN A 369 PHE A 372	ZN A 602 (-3.3A) AKJ A 601 ( 3.9A) AKJ A 601 (-4.1A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	1.50A	1xlxB-5wh6A: 52.3	1xlxB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	12 / 12	TYR A 159 HIS A 160 HIS A 204 MET A 273 THR A 333 ILE A 336 MET A 337 PHE A 340 MET A 357 SER A 368 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None None AKJ A 601 ( 3.9A) AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-2.5A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.57A	1xlxB-5wh6A: 52.3	1xlxB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 ASP A 318 LEU A 319 PRO A 322 TYR A 329 TRP A 332 ILE A 336 MET A 357 SER A 368 PHE A 372	AKJ A 601 ( 4.7A) None ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) None AKJ A 601 (-3.8A) AKJ A 601 (-3.4A) AKJ A 601 (-2.5A) AKJ A 601 (-4.1A)	0.67A	1xmuA-5wh6A: 52.5	1xmuA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	10 / 12	TYR A 159 HIS A 160 ASP A 318 LEU A 319 PRO A 322 TYR A 329 TRP A 332 ILE A 336 PHE A 340 PHE A 372	AKJ A 601 ( 4.7A) None ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) None AKJ A 601 (-3.8A) AKJ A 601 (-4.5A) AKJ A 601 (-4.1A)	0.39A	1xmuA-5wh6A: 52.5	1xmuA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 5	MET A 273 ASN A 321 THR A 333 MET A 337 GLN A 369	AKJ A 601 ( 3.9A) AKJ A 601 (-4.3A) AKJ A 601 (-4.1A) AKJ A 601 ( 3.7A) AKJ A 601 (-3.0A)	0.23A	1xmuA-5wh6A: 52.5	1xmuA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 ASP A 318 LEU A 319 PRO A 322 TYR A 329 TRP A 332 ILE A 336 MET A 357 SER A 368	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) None AKJ A 601 (-3.8A) AKJ A 601 (-3.4A) AKJ A 601 (-2.5A)	0.65A	1xmuB-5wh6A: 52.3	1xmuB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	10 / 12	TYR A 159 HIS A 160 MET A 273 ASP A 318 LEU A 319 PRO A 322 TYR A 329 TRP A 332 ILE A 336 PHE A 340	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) None AKJ A 601 (-3.8A) AKJ A 601 (-4.5A)	0.37A	1xmuB-5wh6A: 52.3	1xmuB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 5	ASN A 321 THR A 333 MET A 337 GLN A 369 PHE A 372	AKJ A 601 (-4.3A) AKJ A 601 (-4.1A) AKJ A 601 ( 3.7A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.18A	1xmuB-5wh6A: 52.3	1xmuB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	6 / 12	TYR A 159 ASP A 201 ILE A 336 MET A 337 PHE A 340 MET A 357	AKJ A 601 ( 4.7A) MG A 603 ( 2.6A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) AKJ A 601 (-4.5A) AKJ A 601 (-3.4A)	1.46A	1xomA-5wh6A: 55.1	1xomA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	10 / 12	TYR A 159 HIS A 160 ASP A 318 LEU A 319 ILE A 336 MET A 337 PHE A 340 MET A 357 SER A 368 GLN A 369	AKJ A 601 ( 4.7A) None ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-2.5A) AKJ A 601 (-3.0A)	0.49A	1xomA-5wh6A: 55.1	1xomA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 ASP A 318 LEU A 319 ILE A 336 MET A 337 PHE A 340 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.25A	1xomA-5wh6A: 55.1	1xomA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	10 / 12	TYR A 159 HIS A 160 LEU A 319 THR A 333 ILE A 336 MET A 337 PHE A 340 MET A 357 SER A 368 GLN A 369	AKJ A 601 ( 4.7A) None AKJ A 601 ( 4.6A) AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-2.5A) AKJ A 601 (-3.0A)	0.46A	1xomB-5wh6A: 55.1	1xomB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 LEU A 319 THR A 333 ILE A 336 MET A 337 PHE A 340 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) AKJ A 601 ( 4.6A) AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.25A	1xomB-5wh6A: 55.1	1xomB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	7 / 12	TYR A 159 HIS A 164 MET A 273 LEU A 319 THR A 333 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) ZN A 602 (-3.3A) AKJ A 601 ( 3.9A) AKJ A 601 ( 4.6A) AKJ A 601 (-4.1A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	1.49A	1xomB-5wh6A: 55.1	1xomB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	7 / 12	LEU A 319 PRO A 322 TYR A 329 THR A 333 ILE A 336 MET A 357 SER A 368	AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 (-3.4A) AKJ A 601 (-2.5A)	0.75A	1xoqA-5wh6A: 55.1	1xoqA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 ASP A 318 LEU A 319 PRO A 322 TYR A 329 THR A 333 ILE A 336 MET A 357 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 (-3.4A) AKJ A 601 (-4.1A)	0.46A	1xoqA-5wh6A: 55.1	1xoqA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	3 / 3	ASN A 321 TRP A 332 GLN A 369	AKJ A 601 (-4.3A) None AKJ A 601 (-3.0A)	0.04A	1xoqA-5wh6A: 55.1	1xoqA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	9 / 12	HIS A 160 LEU A 319 PRO A 322 TYR A 329 TRP A 332 THR A 333 ILE A 336 MET A 357 SER A 368	None AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) None AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 (-3.4A) AKJ A 601 (-2.5A)	0.65A	1xoqB-5wh6A: 55.1	1xoqB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 ASP A 318 LEU A 319 PRO A 322 TYR A 329 TRP A 332 THR A 333 ILE A 336 MET A 357 PHE A 372	AKJ A 601 ( 4.7A) None ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) None AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 (-3.4A) AKJ A 601 (-4.1A)	0.42A	1xoqB-5wh6A: 55.1	1xoqB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	3 / 3	MET A 273 ASN A 321 GLN A 369	AKJ A 601 ( 3.9A) AKJ A 601 (-4.3A) AKJ A 601 (-3.0A)	0.11A	1xoqB-5wh6A: 55.1	1xoqB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 ASP A 318 LEU A 319 MET A 337 PHE A 340 MET A 357 GLN A 369 PHE A 372 ILE A 376	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 ( 3.7A) AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A) None	0.52A	1xosA-5wh6A: 52.3	1xosA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	9 / 12	TYR A 159 HIS A 160 MET A 273 ASP A 318 MET A 337 PHE A 340 SER A 355 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) ZN A 602 (-2.5A) AKJ A 601 ( 3.7A) AKJ A 601 (-4.5A) None AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	1.04A	1xosA-5wh6A: 52.3	1xosA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 12	HIS A 204 MET A 273 SER A 355 MET A 357 ILE A 376	None AKJ A 601 ( 3.9A) None AKJ A 601 (-3.4A) None	1.08A	1xotA-5wh6A: 52.1	1xotA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 LEU A 319 ILE A 336 MET A 337 SER A 355 MET A 357 GLN A 369 PHE A 372 ILE A 376	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) None AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A) None	0.68A	1xotA-5wh6A: 52.1	1xotA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 LEU A 319 ILE A 336 MET A 337 SER A 355 SER A 368 GLN A 369 PHE A 372 ILE A 376	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) None AKJ A 601 (-2.5A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A) None	0.74A	1xotA-5wh6A: 52.1	1xotA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 LEU A 319 ASN A 321 ILE A 336 MET A 337 SER A 355 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) AKJ A 601 ( 4.6A) AKJ A 601 (-4.3A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) None AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.58A	1xotB-5wh6A: 52.1	1xotB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 LEU A 319 ASN A 321 ILE A 336 MET A 337 SER A 355 SER A 368 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) AKJ A 601 ( 4.6A) AKJ A 601 (-4.3A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) None AKJ A 601 (-2.5A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.62A	1xotB-5wh6A: 52.1	1xotB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 11	TYR A 159 HIS A 160 PHE A 340 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 (-4.5A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.37A	2h42A-5wh6A: 36.3	2h42A-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 12	TYR A 159 LEU A 319 PHE A 340 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) AKJ A 601 ( 4.6A) AKJ A 601 (-4.5A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.55A	2h42C-5wh6A: 36.0	2h42C-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_A_EV1A1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	9 / 12	TYR A 159 HIS A 160 LEU A 319 ILE A 336 GLU A 339 PHE A 340 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 4.6A) AKJ A 601 (-3.8A) None AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	1.07A	2weyA-5wh6A: 38.2	2weyA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_A_VDNA1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	6 / 12	TYR A 159 HIS A 160 LEU A 319 PHE A 340 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 4.6A) AKJ A 601 (-4.5A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.68A	3b2rA-5wh6A: 31.3	3b2rA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_B_VDNB1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 11	TYR A 159 HIS A 160 LEU A 319 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 4.6A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.66A	3b2rB-5wh6A: 31.7	3b2rB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CZV_A_AZMA263_1 (CARBONIC ANHYDRASE 13)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 12	HIS A 164 HIS A 200 PHE A 372 THR A 271 VAL A 377	ZN A 602 (-3.3A) ZN A 602 (-3.3A) AKJ A 601 (-4.1A) MG A 603 ( 4.9A) None	1.14A	3czvA-5wh6A: undetectable 3czvB-5wh6A: undetectable	3czvA-5wh6A: undetectable 3czvB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 ASN A 321 PRO A 322 TYR A 329 TRP A 332 THR A 333 ILE A 336 MET A 357 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) AKJ A 601 (-4.3A) AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) None AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 (-3.4A) AKJ A 601 (-4.1A)	0.42A	3g4lA-5wh6A: 54.2	3g4lA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	9 / 12	TYR A 159 HIS A 160 PRO A 322 TYR A 329 TRP A 332 THR A 333 ILE A 336 MET A 357 SER A 368	AKJ A 601 ( 4.7A) None AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) None AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 (-3.4A) AKJ A 601 (-2.5A)	0.66A	3g4lA-5wh6A: 54.2	3g4lA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	12 / 12	TYR A 159 HIS A 160 MET A 273 ASP A 318 LEU A 319 PRO A 322 TRP A 332 THR A 333 ILE A 336 MET A 337 MET A 357 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) None AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) AKJ A 601 (-3.4A) AKJ A 601 (-4.1A)	0.43A	3g4lB-5wh6A: 54.0	3g4lB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_C_ROFC903_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	12 / 12	TYR A 159 HIS A 160 MET A 273 ASP A 318 LEU A 319 ASN A 321 PRO A 322 TYR A 329 TRP A 332 THR A 333 ILE A 336 MET A 357	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-4.3A) AKJ A 601 (-3.9A) AKJ A 601 (-4.8A) None AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 (-3.4A)	0.45A	3g4lC-5wh6A: 54.4	3g4lC-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_D_ROFD904_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 ASP A 318 LEU A 319 PRO A 322 TRP A 332 THR A 333 ILE A 336 MET A 337 GLN A 369	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) ZN A 602 (-2.5A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) None AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) AKJ A 601 (-3.0A)	0.26A	3g4lD-5wh6A: 54.0	3g4lD-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_D_ROFD904_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	11 / 12	TYR A 159 HIS A 160 MET A 273 LEU A 319 PRO A 322 TRP A 332 THR A 333 ILE A 336 MET A 337 SER A 368 GLN A 369	AKJ A 601 ( 4.7A) None AKJ A 601 ( 3.9A) AKJ A 601 ( 4.6A) AKJ A 601 (-3.9A) None AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 ( 3.7A) AKJ A 601 (-2.5A) AKJ A 601 (-3.0A)	0.50A	3g4lD-5wh6A: 54.0	3g4lD-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IA4_C_MTXC164_1 (DIHYDROFOLATE REDUCTASE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 12	ALA A 193 LEU A 260 PHE A 195 ILE A 248 LEU A 241	None	1.26A	3ia4C-5wh6A: undetectable	3ia4C-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	8 / 9	TYR A 159 ASN A 321 ILE A 336 PHE A 340 MET A 357 GLN A 369 PHE A 372 ILE A 376	AKJ A 601 ( 4.7A) AKJ A 601 (-4.3A) AKJ A 601 (-3.8A) AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A) None	0.30A	3iakA-5wh6A: 53.2	3iakA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	8 / 9	TYR A 159 MET A 273 ASN A 321 ILE A 336 PHE A 340 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) AKJ A 601 ( 3.9A) AKJ A 601 (-4.3A) AKJ A 601 (-3.8A) AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.52A	3iakA-5wh6A: 53.2	3iakA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 9	TYR A 159 HIS A 160 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.85A	3jwqA-5wh6A: 39.5	3jwqA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_B_VIAB901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 11	TYR A 159 HIS A 160 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.70A	3jwqB-5wh6A: 39.4 3jwqC-5wh6A: 39.4	3jwqB-5wh6A: undetectable 3jwqC-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_C_VIAC901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 7	TYR A 159 HIS A 160 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.76A	3jwqC-5wh6A: 39.4	3jwqC-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_D_VIAD901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	6 / 11	TYR A 159 HIS A 160 PHE A 340 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) None AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.82A	3jwqA-5wh6A: 39.5 3jwqD-5wh6A: 39.1	3jwqA-5wh6A: undetectable 3jwqD-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TVX_A_PNXA902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	9 / 9	TYR A 159 LEU A 319 ASN A 321 PRO A 322 THR A 333 ILE A 336 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) AKJ A 601 ( 4.6A) AKJ A 601 (-4.3A) AKJ A 601 (-3.9A) AKJ A 601 (-4.1A) AKJ A 601 (-3.8A) AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.48A	3tvxA-5wh6A: 52.3	3tvxA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TVX_B_PNXB902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	7 / 7	TYR A 159 ASN A 321 ILE A 336 PHE A 340 MET A 357 GLN A 369 PHE A 372	AKJ A 601 ( 4.7A) AKJ A 601 (-4.3A) AKJ A 601 (-3.8A) AKJ A 601 (-4.5A) AKJ A 601 (-3.4A) AKJ A 601 (-3.0A) AKJ A 601 (-4.1A)	0.33A	3tvxB-5wh6A: 52.4	3tvxB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AX8_A_SAMA1474_1 (WBDD)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	4 / 6	TYR A 223 ASP A 203 GLU A 243 LEU A 234	None	1.22A	4ax8A-5wh6A: undetectable	4ax8A-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CTZ_B_H4BB600_1 (NITRIC OXIDE SYNTHASE, ENDOTHELIAL)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	4 / 6	PHE A 185 GLU A 182 VAL A 297 ARG A 306	None	1.24A	4ctzA-5wh6A: undetectable 4ctzB-5wh6A: undetectable	4ctzA-5wh6A: undetectable 4ctzB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XI3_D_29SD601_1 (ESTROGEN RECEPTOR)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 12	ALA A 317 TRP A 102 LEU A 175 LEU A 176 MET A 122	None	1.12A	4xi3D-5wh6A: undetectable	4xi3D-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFIC LECTIN)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 8	GLU A 339 VAL A 157 HIS A 160 ASP A 201 HIS A 233	None None None MG A 603 ( 2.6A) None	1.18A	5f8yA-5wh6A: undetectable	5f8yA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFIC LECTIN)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 8	GLU A 339 VAL A 157 HIS A 160 ASP A 201 HIS A 233	None None None MG A 603 ( 2.6A) None	1.20A	5f8yB-5wh6A: undetectable	5f8yB-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FEP_A_SAMA407_0 ([FEFE] HYDROGENASE MATURASE SUBUNIT HYDE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 12	GLN A 369 SER A 368 GLY A 371 MET A 273 TYR A 329	AKJ A 601 (-3.0A) AKJ A 601 (-2.5A) None AKJ A 601 ( 3.9A) AKJ A 601 (-4.8A)	1.31A	5fepA-5wh6A: undetectable	5fepA-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_B_RAUB400_1 (IMINE REDUCTASE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 11	VAL A 169 LEU A 149 TYR A 145 MET A 122 GLY A 237	None	1.20A	5g6sB-5wh6A: 0.6 5g6sC-5wh6A: 0.7	5g6sB-5wh6A: undetectable 5g6sC-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_D_RAUD400_1 (IMINE REDUCTASE)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	5 / 10	VAL A 169 LEU A 149 TYR A 145 MET A 122 GLY A 237	None	1.21A	5g6sD-5wh6A: 0.7 5g6sF-5wh6A: 0.7	5g6sD-5wh6A: undetectable 5g6sF-5wh6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWN_A_AQ4A602_1 (CYTOCHROME P450 1A1)	5wh6	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (Homo sapiens)	4 / 5	ILE A 125 ALA A 166 LEU A 104 LYS A 324	None	0.96A	6dwnA-5wh6A: undetectable	6dwnA-5wh6A: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GSE_A_EAAA224_1","GLUTATHIONE TRANSFERASE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"ARG A 129;LEU A 191;LEU A 260;VAL A 264;ALA A 198","None","1.04A","1gseA-5wh6A:undetectable","1gseA-5wh6A:undetectable"],["1UHO_A_VDNA1000_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",6,"TYR A 159;HIS A 160;PHE A 340;GLN A 369;GLY A 371;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 (-4.5A);AKJ A 601 (-3.0A);None;AKJ A 601 (-4.1A)","0.33A","1uhoA-5wh6A:36.6","1uhoA-5wh6A:undetectable"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"HIS A 200;MET A 273;THR A 333;GLN A 369;PHE A 372"," ZN A 602 (-3.3A);AKJ A 601 ( 3.9A);AKJ A 601 (-4.1A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","1.49A","1xlxA-5wh6A:52.2","1xlxA-5wh6A:undetectable"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",12,"TYR A 159;HIS A 160;HIS A 204;MET A 273;LEU A 319;ASN A 321;THR A 333;ILE A 336;MET A 337;SER A 368;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;None;AKJ A 601 ( 3.9A);AKJ A 601 ( 4.6A);AKJ A 601 (-4.3A);AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);AKJ A 601 (-2.5A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.43A","1xlxA-5wh6A:52.2","1xlxA-5wh6A:undetectable"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"HIS A 200;MET A 273;THR A 333;GLN A 369;PHE A 372"," ZN A 602 (-3.3A);AKJ A 601 ( 3.9A);AKJ A 601 (-4.1A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","1.50A","1xlxB-5wh6A:52.3","1xlxB-5wh6A:undetectable"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",12,"TYR A 159;HIS A 160;HIS A 204;MET A 273;THR A 333;ILE A 336;MET A 337;PHE A 340;MET A 357;SER A 368;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;None;AKJ A 601 ( 3.9A);AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-2.5A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.57A","1xlxB-5wh6A:52.3","1xlxB-5wh6A:undetectable"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;ASP A 318;LEU A 319;PRO A 322;TYR A 329;TRP A 332;ILE A 336;MET A 357;SER A 368;PHE A 372","AKJ A 601 ( 4.7A);None; ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);None;AKJ A 601 (-3.8A);AKJ A 601 (-3.4A);AKJ A 601 (-2.5A);AKJ A 601 (-4.1A)","0.67A","1xmuA-5wh6A:52.5","1xmuA-5wh6A:undetectable"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",10,"TYR A 159;HIS A 160;ASP A 318;LEU A 319;PRO A 322;TYR A 329;TRP A 332;ILE A 336;PHE A 340;PHE A 372","AKJ A 601 ( 4.7A);None; ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);None;AKJ A 601 (-3.8A);AKJ A 601 (-4.5A);AKJ A 601 (-4.1A)","0.39A","1xmuA-5wh6A:52.5","1xmuA-5wh6A:undetectable"],["1XMU_A_ROFA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"MET A 273;ASN A 321;THR A 333;MET A 337;GLN A 369","AKJ A 601 ( 3.9A);AKJ A 601 (-4.3A);AKJ A 601 (-4.1A);AKJ A 601 ( 3.7A);AKJ A 601 (-3.0A)","0.23A","1xmuA-5wh6A:52.5","1xmuA-5wh6A:undetectable"],["1XMU_B_ROFB102_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;ASP A 318;LEU A 319;PRO A 322;TYR A 329;TRP A 332;ILE A 336;MET A 357;SER A 368","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A); ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);None;AKJ A 601 (-3.8A);AKJ A 601 (-3.4A);AKJ A 601 (-2.5A)","0.65A","1xmuB-5wh6A:52.3","1xmuB-5wh6A:undetectable"],["1XMU_B_ROFB102_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",10,"TYR A 159;HIS A 160;MET A 273;ASP A 318;LEU A 319;PRO A 322;TYR A 329;TRP A 332;ILE A 336;PHE A 340","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A); ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);None;AKJ A 601 (-3.8A);AKJ A 601 (-4.5A)","0.37A","1xmuB-5wh6A:52.3","1xmuB-5wh6A:undetectable"],["1XMU_B_ROFB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"ASN A 321;THR A 333;MET A 337;GLN A 369;PHE A 372","AKJ A 601 (-4.3A);AKJ A 601 (-4.1A);AKJ A 601 ( 3.7A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.18A","1xmuB-5wh6A:52.3","1xmuB-5wh6A:undetectable"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",6,"TYR A 159;ASP A 201;ILE A 336;MET A 337;PHE A 340;MET A 357","AKJ A 601 ( 4.7A); MG A 603 ( 2.6A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);AKJ A 601 (-4.5A);AKJ A 601 (-3.4A)","1.46A","1xomA-5wh6A:55.1","1xomA-5wh6A:undetectable"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",10,"TYR A 159;HIS A 160;ASP A 318;LEU A 319;ILE A 336;MET A 337;PHE A 340;MET A 357;SER A 368;GLN A 369","AKJ A 601 ( 4.7A);None; ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-2.5A);AKJ A 601 (-3.0A)","0.49A","1xomA-5wh6A:55.1","1xomA-5wh6A:undetectable"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;ASP A 318;LEU A 319;ILE A 336;MET A 337;PHE A 340;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A); ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.25A","1xomA-5wh6A:55.1","1xomA-5wh6A:undetectable"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",10,"TYR A 159;HIS A 160;LEU A 319;THR A 333;ILE A 336;MET A 337;PHE A 340;MET A 357;SER A 368;GLN A 369","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 4.6A);AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-2.5A);AKJ A 601 (-3.0A)","0.46A","1xomB-5wh6A:55.1","1xomB-5wh6A:undetectable"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;LEU A 319;THR A 333;ILE A 336;MET A 337;PHE A 340;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A);AKJ A 601 ( 4.6A);AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.25A","1xomB-5wh6A:55.1","1xomB-5wh6A:undetectable"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",7,"TYR A 159;HIS A 164;MET A 273;LEU A 319;THR A 333;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A); ZN A 602 (-3.3A);AKJ A 601 ( 3.9A);AKJ A 601 ( 4.6A);AKJ A 601 (-4.1A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","1.49A","1xomB-5wh6A:55.1","1xomB-5wh6A:undetectable"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",7,"LEU A 319;PRO A 322;TYR A 329;THR A 333;ILE A 336;MET A 357;SER A 368","AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 (-3.4A);AKJ A 601 (-2.5A)","0.75A","1xoqA-5wh6A:55.1","1xoqA-5wh6A:undetectable"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;ASP A 318;LEU A 319;PRO A 322;TYR A 329;THR A 333;ILE A 336;MET A 357;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A); ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 (-3.4A);AKJ A 601 (-4.1A)","0.46A","1xoqA-5wh6A:55.1","1xoqA-5wh6A:undetectable"],["1XOQ_A_ROFA502_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",3,"ASN A 321;TRP A 332;GLN A 369","AKJ A 601 (-4.3A);None;AKJ A 601 (-3.0A)","0.04A","1xoqA-5wh6A:55.1","1xoqA-5wh6A:undetectable"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",9,"HIS A 160;LEU A 319;PRO A 322;TYR A 329;TRP A 332;THR A 333;ILE A 336;MET A 357;SER A 368","None;AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);None;AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 (-3.4A);AKJ A 601 (-2.5A)","0.65A","1xoqB-5wh6A:55.1","1xoqB-5wh6A:undetectable"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;ASP A 318;LEU A 319;PRO A 322;TYR A 329;TRP A 332;THR A 333;ILE A 336;MET A 357;PHE A 372","AKJ A 601 ( 4.7A);None; ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);None;AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 (-3.4A);AKJ A 601 (-4.1A)","0.42A","1xoqB-5wh6A:55.1","1xoqB-5wh6A:undetectable"],["1XOQ_B_ROFB501_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",3,"MET A 273;ASN A 321;GLN A 369","AKJ A 601 ( 3.9A);AKJ A 601 (-4.3A);AKJ A 601 (-3.0A)","0.11A","1xoqB-5wh6A:55.1","1xoqB-5wh6A:undetectable"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;ASP A 318;LEU A 319;MET A 337;PHE A 340;MET A 357;GLN A 369;PHE A 372;ILE A 376","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A); ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 ( 3.7A);AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A);None","0.52A","1xosA-5wh6A:52.3","1xosA-5wh6A:undetectable"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",9,"TYR A 159;HIS A 160;MET A 273;ASP A 318;MET A 337;PHE A 340;SER A 355;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A); ZN A 602 (-2.5A);AKJ A 601 ( 3.7A);AKJ A 601 (-4.5A);None;AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","1.04A","1xosA-5wh6A:52.3","1xosA-5wh6A:undetectable"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"HIS A 204;MET A 273;SER A 355;MET A 357;ILE A 376","None;AKJ A 601 ( 3.9A);None;AKJ A 601 (-3.4A);None","1.08A","1xotA-5wh6A:52.1","1xotA-5wh6A:undetectable"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;LEU A 319;ILE A 336;MET A 337;SER A 355;MET A 357;GLN A 369;PHE A 372;ILE A 376","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);None;AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A);None","0.68A","1xotA-5wh6A:52.1","1xotA-5wh6A:undetectable"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;LEU A 319;ILE A 336;MET A 337;SER A 355;SER A 368;GLN A 369;PHE A 372;ILE A 376","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);None;AKJ A 601 (-2.5A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A);None","0.74A","1xotA-5wh6A:52.1","1xotA-5wh6A:undetectable"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;LEU A 319;ASN A 321;ILE A 336;MET A 337;SER A 355;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A);AKJ A 601 ( 4.6A);AKJ A 601 (-4.3A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);None;AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.58A","1xotB-5wh6A:52.1","1xotB-5wh6A:undetectable"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;LEU A 319;ASN A 321;ILE A 336;MET A 337;SER A 355;SER A 368;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A);AKJ A 601 ( 4.6A);AKJ A 601 (-4.3A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);None;AKJ A 601 (-2.5A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.62A","1xotB-5wh6A:52.1","1xotB-5wh6A:undetectable"],["2H42_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"TYR A 159;HIS A 160;PHE A 340;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 (-4.5A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.37A","2h42A-5wh6A:36.3","2h42A-5wh6A:undetectable"],["2H42_C_VIAC903_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"TYR A 159;LEU A 319;PHE A 340;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);AKJ A 601 ( 4.6A);AKJ A 601 (-4.5A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.55A","2h42C-5wh6A:36.0","2h42C-5wh6A:undetectable"],["2WEY_A_EV1A1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",9,"TYR A 159;HIS A 160;LEU A 319;ILE A 336;GLU A 339;PHE A 340;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 4.6A);AKJ A 601 (-3.8A);None;AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","1.07A","2weyA-5wh6A:38.2","2weyA-5wh6A:undetectable"],["3B2R_A_VDNA1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",6,"TYR A 159;HIS A 160;LEU A 319;PHE A 340;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 4.6A);AKJ A 601 (-4.5A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.68A","3b2rA-5wh6A:31.3","3b2rA-5wh6A:undetectable"],["3B2R_B_VDNB1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"TYR A 159;HIS A 160;LEU A 319;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 4.6A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.66A","3b2rB-5wh6A:31.7","3b2rB-5wh6A:undetectable"],["3CZV_A_AZMA263_1","CARBONIC ANHYDRASE 13;CARBONIC ANHYDRASE 13","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"HIS A 164;HIS A 200;PHE A 372;THR A 271;VAL A 377"," ZN A 602 (-3.3A); ZN A 602 (-3.3A);AKJ A 601 (-4.1A); MG A 603 ( 4.9A);None","1.14A","3czvA-5wh6A:undetectable;3czvB-5wh6A:undetectable","3czvA-5wh6A:undetectable;3czvB-5wh6A:undetectable"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;ASN A 321;PRO A 322;TYR A 329;TRP A 332;THR A 333;ILE A 336;MET A 357;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A);AKJ A 601 (-4.3A);AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);None;AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 (-3.4A);AKJ A 601 (-4.1A)","0.42A","3g4lA-5wh6A:54.2","3g4lA-5wh6A:undetectable"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",9,"TYR A 159;HIS A 160;PRO A 322;TYR A 329;TRP A 332;THR A 333;ILE A 336;MET A 357;SER A 368","AKJ A 601 ( 4.7A);None;AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);None;AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 (-3.4A);AKJ A 601 (-2.5A)","0.66A","3g4lA-5wh6A:54.2","3g4lA-5wh6A:undetectable"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",12,"TYR A 159;HIS A 160;MET A 273;ASP A 318;LEU A 319;PRO A 322;TRP A 332;THR A 333;ILE A 336;MET A 337;MET A 357;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A); ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);None;AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);AKJ A 601 (-3.4A);AKJ A 601 (-4.1A)","0.43A","3g4lB-5wh6A:54.0","3g4lB-5wh6A:undetectable"],["3G4L_C_ROFC903_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",12,"TYR A 159;HIS A 160;MET A 273;ASP A 318;LEU A 319;ASN A 321;PRO A 322;TYR A 329;TRP A 332;THR A 333;ILE A 336;MET A 357","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A); ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-4.3A);AKJ A 601 (-3.9A);AKJ A 601 (-4.8A);None;AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 (-3.4A)","0.45A","3g4lC-5wh6A:54.4","3g4lC-5wh6A:undetectable"],["3G4L_D_ROFD904_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;ASP A 318;LEU A 319;PRO A 322;TRP A 332;THR A 333;ILE A 336;MET A 337;GLN A 369","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A); ZN A 602 (-2.5A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);None;AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);AKJ A 601 (-3.0A)","0.26A","3g4lD-5wh6A:54.0","3g4lD-5wh6A:undetectable"],["3G4L_D_ROFD904_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",11,"TYR A 159;HIS A 160;MET A 273;LEU A 319;PRO A 322;TRP A 332;THR A 333;ILE A 336;MET A 337;SER A 368;GLN A 369","AKJ A 601 ( 4.7A);None;AKJ A 601 ( 3.9A);AKJ A 601 ( 4.6A);AKJ A 601 (-3.9A);None;AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 ( 3.7A);AKJ A 601 (-2.5A);AKJ A 601 (-3.0A)","0.50A","3g4lD-5wh6A:54.0","3g4lD-5wh6A:undetectable"],["3IA4_C_MTXC164_1","DIHYDROFOLATE REDUCTASE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"ALA A 193;LEU A 260;PHE A 195;ILE A 248;LEU A 241","None","1.26A","3ia4C-5wh6A:undetectable","3ia4C-5wh6A:undetectable"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",8,"TYR A 159;ASN A 321;ILE A 336;PHE A 340;MET A 357;GLN A 369;PHE A 372;ILE A 376","AKJ A 601 ( 4.7A);AKJ A 601 (-4.3A);AKJ A 601 (-3.8A);AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A);None","0.30A","3iakA-5wh6A:53.2","3iakA-5wh6A:undetectable"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",8,"TYR A 159;MET A 273;ASN A 321;ILE A 336;PHE A 340;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);AKJ A 601 ( 3.9A);AKJ A 601 (-4.3A);AKJ A 601 (-3.8A);AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.52A","3iakA-5wh6A:53.2","3iakA-5wh6A:undetectable"],["3JWQ_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"TYR A 159;HIS A 160;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.85A","3jwqA-5wh6A:39.5","3jwqA-5wh6A:undetectable"],["3JWQ_B_VIAB901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA;CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"TYR A 159;HIS A 160;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.70A","3jwqB-5wh6A:39.4;3jwqC-5wh6A:39.4","3jwqB-5wh6A:undetectable;3jwqC-5wh6A:undetectable"],["3JWQ_C_VIAC901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"TYR A 159;HIS A 160;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.76A","3jwqC-5wh6A:39.4","3jwqC-5wh6A:undetectable"],["3JWQ_D_VIAD901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA;CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",6,"TYR A 159;HIS A 160;PHE A 340;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);None;AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.82A","3jwqA-5wh6A:39.5;3jwqD-5wh6A:39.1","3jwqA-5wh6A:undetectable;3jwqD-5wh6A:undetectable"],["3TVX_A_PNXA902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",9,"TYR A 159;LEU A 319;ASN A 321;PRO A 322;THR A 333;ILE A 336;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);AKJ A 601 ( 4.6A);AKJ A 601 (-4.3A);AKJ A 601 (-3.9A);AKJ A 601 (-4.1A);AKJ A 601 (-3.8A);AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.48A","3tvxA-5wh6A:52.3","3tvxA-5wh6A:undetectable"],["3TVX_B_PNXB902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",7,"TYR A 159;ASN A 321;ILE A 336;PHE A 340;MET A 357;GLN A 369;PHE A 372","AKJ A 601 ( 4.7A);AKJ A 601 (-4.3A);AKJ A 601 (-3.8A);AKJ A 601 (-4.5A);AKJ A 601 (-3.4A);AKJ A 601 (-3.0A);AKJ A 601 (-4.1A)","0.33A","3tvxB-5wh6A:52.4","3tvxB-5wh6A:undetectable"],["4AX8_A_SAMA1474_1","WBDD","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",4,"TYR A 223;ASP A 203;GLU A 243;LEU A 234","None","1.22A","4ax8A-5wh6A:undetectable","4ax8A-5wh6A:undetectable"],["4CTZ_B_H4BB600_1","NITRIC OXIDE SYNTHASE, ENDOTHELIAL;NITRIC OXIDE SYNTHASE, ENDOTHELIAL","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",4,"PHE A 185;GLU A 182;VAL A 297;ARG A 306","None","1.24A","4ctzA-5wh6A:undetectable;4ctzB-5wh6A:undetectable","4ctzA-5wh6A:undetectable;4ctzB-5wh6A:undetectable"],["4XI3_D_29SD601_1","ESTROGEN RECEPTOR","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"ALA A 317;TRP A 102;LEU A 175;LEU A 176;MET A 122","None","1.12A","4xi3D-5wh6A:undetectable","4xi3D-5wh6A:undetectable"],["5F8Y_A_X6XA202_1","GALNAC\/GAL-SPECIFIC LECTIN","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"GLU A 339;VAL A 157;HIS A 160;ASP A 201;HIS A 233","None;None;None; MG A 603 ( 2.6A);None","1.18A","5f8yA-5wh6A:undetectable","5f8yA-5wh6A:undetectable"],["5F8Y_B_X6XB201_1","GALNAC\/GAL-SPECIFIC LECTIN","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"GLU A 339;VAL A 157;HIS A 160;ASP A 201;HIS A 233","None;None;None; MG A 603 ( 2.6A);None","1.20A","5f8yB-5wh6A:undetectable","5f8yB-5wh6A:undetectable"],["5FEP_A_SAMA407_0","[FEFE] HYDROGENASE MATURASE SUBUNIT HYDE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"GLN A 369;SER A 368;GLY A 371;MET A 273;TYR A 329","AKJ A 601 (-3.0A);AKJ A 601 (-2.5A);None;AKJ A 601 ( 3.9A);AKJ A 601 (-4.8A)","1.31A","5fepA-5wh6A:undetectable","5fepA-5wh6A:undetectable"],["5G6S_B_RAUB400_1","IMINE REDUCTASE;IMINE REDUCTASE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"VAL A 169;LEU A 149;TYR A 145;MET A 122;GLY A 237","None","1.20A","5g6sB-5wh6A:0.6;5g6sC-5wh6A:0.7","5g6sB-5wh6A:undetectable;5g6sC-5wh6A:undetectable"],["5G6S_D_RAUD400_1","IMINE REDUCTASE;IMINE REDUCTASE","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",5,"VAL A 169;LEU A 149;TYR A 145;MET A 122;GLY A 237","None","1.21A","5g6sD-5wh6A:0.7;5g6sF-5wh6A:0.7","5g6sD-5wh6A:undetectable;5g6sF-5wh6A:undetectable"],["6DWN_A_AQ4A602_1","CYTOCHROME P450 1A1","5wh6","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","Homo sapiens",4,"ILE A 125;ALA A 166;LEU A 104;LYS A 324","None","0.96A","6dwnA-5wh6A:undetectable","6dwnA-5wh6A:undetectable"]]